Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease

D. Stolz, T. Breidthardt, M. Christ-Crain, R. Bingisser, D. Miedinger, J. Leuppi, B. Müller, M. Tamm, C. Müller (Basel, Switzerland)

Source: Annual Congress 2008 - COPD
Session: COPD
Session type: E-Communication Session
Number: 4665
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Stolz, T. Breidthardt, M. Christ-Crain, R. Bingisser, D. Miedinger, J. Leuppi, B. Müller, M. Tamm, C. Müller (Basel, Switzerland). Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2008; 32: Suppl. 52, 4665

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Thierry Rochat - 08.10.2008 10:13
question
Did you also do a ROC analysis for ICU amission and how does it look like ?
You must Login to comment this presentation.


Related content which might interest you:
The role of amino-terminal pro-brain natriuretic peptide (NT-proBNP in clinical evaluation of patient with acute exacerbation chronic obstructive pulmonary disease
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014

Brtain natriuretic peptide in chronic obstructive pulmonary disease under stable state and respiratory failure
Source: Eur Respir J 2003; 22: Suppl. 45, 269s
Year: 2003

The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007


Brain natriuretic peptides in patients with idiopathic pulmonary hypertension and chronic thromboembolic disease
Source: Annual Congress 2007 - Venous thromboembolic disease
Year: 2007


Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide
Source: Annual Congress 2007 - New insight into the pathophysiology of asthma
Year: 2007


The effects of elevated troponin I on long-term mortality after chronic obstructive pulmonary disease exacerbation
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009


Pro-adrenomedullin and pro-endothelin-1 for assessment and prognosis of acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 39s
Year: 2007

Atrial fibrillation as a relevant comorbidity in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017

Elevation of cardiac troponin-I predicts long-term mortality in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009

Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012


Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007


N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013


Predictors of high-sensitivity cardiac troponin T during acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011


Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


The diagnostic value of N-terminal pro-C-type natriuretic peptide in COPD patients with pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015


Acute exacerbations of chronic obstructive pulmonary disease: Impact of cardiovascular co-morbidities
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010


The role of neutrophil/lymphocyte ratio in acute exacerbations of chronic obstructive pulmonary disease COPD
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020


Heart arrhythmias in patients with chronic obstructive bronchitis and ischemic heart disease
Source: Eur Respir J 2004; 24: Suppl. 48, 277s
Year: 2004

NT-proBNP, troponin T and left ventricular function in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012

Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation
Source: Eur Respir J 2008; 31: 563-570
Year: 2008